Report overview
This report contains market size and forecasts of Myasthenia Gravis Drugs in global, including the following market information:
Global Myasthenia Gravis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Myasthenia Gravis Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Myasthenia Gravis Drugs companies in 2021 (%)
The global Myasthenia Gravis Drugs market was valued at 1467.3 million in 2021 and is projected to reach US$ 2400 million by 2028, at a CAGR of 7.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticholinesterases Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Myasthenia Gravis Drugs include Flamel Technologies, F. Hoffmann-La Roche, Grifols, Pfizer, Takeda, Novartis, Bausch Health, Alexion Pharmaceuticals and Catalyst Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Myasthenia Gravis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myasthenia Gravis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, by Type, 2021 (%)
Anticholinesterases
Immunosuppressants
Intravenous Immune Globulins
Global Myasthenia Gravis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Myasthenia Gravis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Myasthenia Gravis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myasthenia Gravis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Myasthenia Gravis Drugs revenues share in global market, 2021 (%)
Key companies Myasthenia Gravis Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Myasthenia Gravis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Flamel Technologies
F. Hoffmann-La Roche
Grifols
Pfizer
Takeda
Novartis
Bausch Health
Alexion Pharmaceuticals
Catalyst Pharmaceuticals
CSL
Curavac
Cytokinetics
Galencia
GlaxoSmithKline
Lupin Pharmaceuticals
Mitsubishi Tanabe Pharma
